Online Database of Chemicals from Around the World

D-Galactopyranose pentaacetate
[CAS# 25878-60-8]

List of Suppliers
Simagchem Corporation China Inquire  
+86 13806087780
sale@simagchem.com
Chemical manufacturer since 2002
chemBlink standard supplier since 2008
Zhejiang Synose Tech Co., Ltd. China Inquire  
+86(579)8227-5537
8917-2081
expo@synose.com
Chemical manufacturer since 1996
chemBlink standard supplier since 2011
Biosynth AG. Switzerland Inquire  
+41 (71) 858-2020
welcome@biosynth.ch
Chemical manufacturer
chemBlink standard supplier since 2014
Hangzhou Leap Chem Co., Ltd. China Inquire  
+86 (571) 8771-1850
market19@leapchem.com
QQ chat
Chemical manufacturer since 2006
chemBlink standard supplier since 2015
City Chemical LLC USA Inquire  
+1 (203) 932-2489
sales@citychemical.com
Chemical distributor
Complete supplier list of D-Galactopyranose pentaacetate
Identification
Classification Biochemical >> Carbohydrate >> Monosaccharide
Name D-Galactopyranose pentaacetate
Synonyms 1,2,3,4,6-Penta-O-acetyl-D-galactopyranose
Molecular Structure CAS # 25878-60-8, D-Galactopyranose pentaacetate, 1,2,3,4,6-Penta-O-acetyl-D-galactopyranose
Molecular Formula C16H22O11
Molecular Weight 390.34
CAS Registry Number 25878-60-8
EC Number 898-007-4
SMILES CC(=O)OC[C@@H]1[C@@H]([C@@H]([C@H](C(O1)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C
Properties
Density 1.3±0.1 g/cm3 Calc.*
Boiling point 434.8±45.0 ºC 760 mmHg (Calc.)*
Flash point 188.1±28.8 ºC (Calc.)*
Index of refraction 1.482 (Calc.)*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbols symbol   GHS07 Warning    Details
Hazard Statements H315-H319-H335    Details
Precautionary Statements P261-P264-P264+P265-P271-P280-P302+P352-P304+P340-P305+P351+P338-P319-P321-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Specific target organ toxicity - single exposureSTOT SE3H335
Eye irritationEye Irrit.2AH319
Skin irritationSkin Irrit.2H315
SDS Available
up Discovory and Applicatios
D-Galactopyranose pentaacetate is the fully acetylated derivative of D-galactopyranose in which all five hydroxyl groups of the monosaccharide are converted to acetate esters. D-galactose was identified in the nineteenth century during investigations of lactose hydrolysis, when it was recognized as one of the constituent sugars of milk sugar. Subsequent structural studies established that D-galactose is an aldohexose closely related to D-glucose, differing in configuration at the C-4 position. The pyranose form, a six-membered cyclic hemiacetal, was shown to predominate in solution and in crystalline derivatives.

The preparation of peracetylated sugars such as D-galactopyranose pentaacetate emerged as a central method in classical carbohydrate chemistry. Treatment of D-galactose with acetic anhydride, commonly in the presence of basic catalysts such as pyridine or sodium acetate, converts the hydroxyl groups at positions 1, 2, 3, 4, and 6 into acetate esters. This reaction proceeds under controlled conditions to minimize degradation and yields a crystalline product that is significantly less hygroscopic than the parent sugar. The formation of well-defined acetylated derivatives provided chemists with stable compounds suitable for purification and analysis at a time when spectroscopic methods were not yet available.

D-galactopyranose pentaacetate played an important role in confirming the ring size and configuration of galactose. The isolation of distinct anomeric forms, corresponding to alpha and beta configurations at the anomeric carbon, supported the concept of mutarotation and the cyclic structure of monosaccharides. Measurement of melting points, optical rotation, and derivative interconversions allowed researchers to compare theoretical structural proposals with experimental results. These studies contributed to the broader validation of the Haworth representation of pyranose sugars and to the systematic understanding of stereochemistry in carbohydrates.

Beyond structural elucidation, D-galactopyranose pentaacetate has served as a versatile intermediate in synthetic carbohydrate chemistry. The acetyl groups protect the hydroxyl functions, reducing intermolecular hydrogen bonding and increasing solubility in organic solvents such as chloroform, dichloromethane, and ethyl acetate. This property enables further transformations that would be difficult to achieve with the free sugar. In particular, activation of the anomeric acetate under suitable conditions allows the compound to function as a glycosyl donor in the synthesis of glycosides. Controlled deacetylation can subsequently regenerate specific hydroxyl groups for additional modification.

Peracetylated monosaccharides have also been used in mechanistic studies of glycosylation reactions. The electron-withdrawing nature of the acetyl substituents influences the stability of intermediate species formed during substitution at the anomeric center. Experimental investigations of reaction rates and stereochemical outcomes have relied on compounds such as D-galactopyranose pentaacetate to clarify principles governing neighboring group participation and anomeric selectivity. These findings have had lasting impact on the design of oligosaccharide synthesis strategies.

In addition, acetylated galactose derivatives have been employed as starting materials in the preparation of biologically relevant molecules, including galactosides and glycoconjugates. The controlled protection and deprotection sequences made possible by acetyl groups have enabled the stepwise assembly of more complex carbohydrate structures. Although D-galactopyranose pentaacetate itself is primarily an intermediate rather than an end-use product, its historical and practical importance is well documented in the literature of carbohydrate chemistry.

Through its contribution to structural analysis, synthetic methodology, and mechanistic understanding, D-galactopyranose pentaacetate exemplifies the role of protected sugar derivatives in the advancement of glycochemistry. Its preparation and applications are grounded in experimentally established principles that continue to inform modern research in carbohydrate science.

References

2023. A guide for the synthesis of key nucleoside scaffolds in drug discovery. Medicinal Chemistry Research.
DOI: 10.1007/s00044-023-03096-w

2021. Synthesis of a Key Subunit of HIV-1 Protease Inhibitor Darunavir. Synfacts.
DOI: 10.1055/s-0040-1719792

2019. Synthesis of a cGAMP Analogue. Synfacts.
DOI: 10.1055/s-0037-1612408
Market Analysis Reports
List of Reports Available for D-Galactopyranose pentaacetate
Related Products
Gadoteric acid  Gadoteridol  Gadoxetate disodium  D-Galactal  D-Galacto-L-arabinan  D-Galacto-L-Arabinan, 2-hydroxy-3-(trimethylammonio)propyl ether, chloride  Galacto-6-deoxygalactan  alpha-D-Galactofuranosylnitromethane  D-Galactono-1,4-lactone  alpha-D-Galactopyranose 1,2,3,4,6-pentaacetate  beta-D-Galactopyranose pentabenzoate  beta-D-Galactopyranoside 4-aminophenyl  alpha-D-Galactopyranoside 6-chloro-1H-indol-3-yl  O-beta-D-Galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→3)-O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→6)-O-[O-beta-D-galactopyranosyl-(1→3)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→3)]-O-beta-D-galactopyranosyl-(1→4)-D-glucose  O-beta-D-Galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)-O-beta-D-galactopyranosyl-(1→6)-O-[2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)]-O-[beta-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)-O-beta-D-mannopyranosyl-(1→3)]-O-beta-D-mannopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)-O[6-deoxy-beta-D-galactopyranosyl-(1→6)]-2-(acetylamino)-2-deoxy-D-glucose  O-beta-D-Galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→3)-O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→3)-O-beta-D-galactopyranosyl-(1→4)-D-glucose  O-beta-D-Galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→3)-O-[O-beta-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→6)]-O-beta-D-galactopyranosyl-(1→4)-D-glucose  O-beta-D-Galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)-O-[O-beta-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)]-O-alpha-D-mannopyranosyl-(1→3)-O-[O-beta-D-galactopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→2)-alpha-D-mannopyranosyl-(1→6)]-O-beta-D-mannopyranosyl-(1→4)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-D-glucose  O-beta-D-Galactopyranosyl-(1→3)-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→3)-O-beta-D-galactopyranosyl-(1→4)-O-[6-deoxy-alpha-L-galactopyranosyl-(1→3)]-O-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→6)-O-[O-beta-D-galactopyranosyl-(1→3)-2-(acetylamino)-2-deoxy-beta-D-glucopyranosyl-(1→3)]-O-beta-D-galactopyranosyl-(1→4)-D-glucose  Gabapentin-lactam